Fresenius SE & Co KGaA (OTCQX International Premier:FSNUY)

11.99
Delayed Data
As of Dec 12
 +0.82 / +7.34%
Today’s Change
11.00
Today|||52-Week Range
22.05
-38.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$31.0B

Company Description

Fresenius SE & Co. KGaA is a global healthcare group, which engages in the provision of products, and services for dialysis, hospitals, and outpatient medical care. It operates through the following business segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate & Other. The Fresenius Medical Care segment is comprised of dialysis products, and healthcare services. The Fresenius Kabi segment provides intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios is the hospital operations. The Fresenius Vamed is consist of projects, and services for hospitals and other healthcare facilities. The Corporate & Other segment engages in the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Contact Information

Fresenius SE & Co. KGaA
Else-Kröner-Strasse 1
Bad Homburg Hessen 61352
P:(496) 172-6080
Investor Relations:
4961726082485

Employees

Shareholders

Other institutional0.05%
Mutual fund holders0.00%
Individual stakeholders--

Top Executives

Stephan SturmPresident & Chief Executive Officer
Rachel Clare EmpeyChief Financial Officer
Jürgen GötzChief Legal & Compliance Officer
Francesco de MeoChief Executive Officer-Fresenius Helios
Mats Christer HenrikssonChief Executive Officer-Fresenius Kabi